NCT02473094 Neoadjuvant Metformin in Association to Chemoradiotherapy for Locally Advanced Rectal Cancer Status TERMINATED Phase PHASE2
NCT02465593 A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT02460419 Maintenance Capecitabine Plus Best Supportive Care Versus Best Supportive Care for Metastatic Nasopharyngeal Carcinoma Status COMPLETED Phase PHASE3
NCT02451553 Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary Cancer Status COMPLETED Phase PHASE1
NCT02445391 Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02422199 A Study of Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+Metastatic Breast Cancer Who Have Prior Received Anthracyclin, Taxane or Trastuzumab Status UNKNOWN Phase PHASE1/PHASE2
NCT02419495 Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies Status TERMINATED Phase PHASE1
NCT02414009 Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer Patients Status COMPLETED Phase PHASE2
NCT02403544 Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma Status UNKNOWN Phase PHASE1
NCT02395640 The Comparison of XELOX and EOX in the First-line Treatment of Advanced Gastric Cancer Status COMPLETED Phase PHASE3
NCT02394535 Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT02393755 Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02371304 Rectal Preserving Treatment for Early Rectal Cancer. A Multi-centred Randomised Trial of Radical Surgery Versus Adjuvant Chemoradiotherapy After Local Excision for Early Rectal Cancers Status UNKNOWN Phase PHASE3
NCT02360501 Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma Status COMPLETED Phase PHASE2
NCT02359058 A Study of Ramucirumab Combination Therapy in Japanese Participants Who Have Advanced Stomach Cancer Status COMPLETED Phase PHASE1
NCT02358356 Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study Status COMPLETED Phase PHASE2
NCT02354612 Open Label Continuation Study of TRC105 for Patients Who Have Completed a Prior TRC105 Trial Status NO_LONGER_AVAILABLE Phase N/A
NCT02352831 Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma Status TERMINATED Phase PHASE1/PHASE2
NCT02350686 XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based Chemotherapy Status UNKNOWN Phase PHASE2